These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1672278)

  • 1. Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis.
    Guelrud M; Mendoza S; Viera L; Gelrud D
    Gastrointest Endosc; 1991; 37(1):44-7. PubMed ID: 1672278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy.
    Bordas JM; Toledo V; Mondelo F; Rodés J
    Horm Res; 1988; 29(2-3):106-8. PubMed ID: 2900187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography.
    Chan HH; Lai KH; Lin CK; Tsai WL; Lo GH; Hsu PI; Wei MC; Wang EM
    J Chin Med Assoc; 2008 Dec; 71(12):605-9. PubMed ID: 19114324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERCP- and endoscopic sphincterotomy-induced pancreatitis.
    Sherman S; Lehman GA
    Pancreas; 1991 May; 6(3):350-67. PubMed ID: 1713676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
    Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
    J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study.
    Bordas JM; Toledo-Pimentel V; Llach J; Elena M; Mondelo F; Ginès A; Terés J
    Gastrointest Endosc; 1998 Mar; 47(3):230-4. PubMed ID: 9540874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.
    Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST
    Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
    Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
    Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertensive pancreatic duct sphincter as a cause of pancreatitis. Successful treatment with hydrostatic balloon dilatation.
    Guelrud M; Siegel JH
    Dig Dis Sci; 1984 Mar; 29(3):225-31. PubMed ID: 6697862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sphincter of Oddi disfunction in "idiopathic" recurrent pancreatitis].
    Wehrmann T; Zipf A; Caspary WF; Jung M
    Dtsch Med Wochenschr; 1996 Jun; 121(24):781-7. PubMed ID: 8654212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
    Andriulli A; Clemente R; Solmi L; Terruzzi V; Suriani R; Sigillito A; Leandro G; Leo P; De Maio G; Perri F
    Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
    Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
    Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
    Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.
    Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R;
    Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.
    Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis.
    Coté GA; Imperiale TF; Schmidt SE; Fogel E; Lehman G; McHenry L; Watkins J; Sherman S
    Gastroenterology; 2012 Dec; 143(6):1502-1509.e1. PubMed ID: 22982183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.
    Tarnasky PR; Palesch YY; Cunningham JT; Mauldin PD; Cotton PB; Hawes RH
    Gastroenterology; 1998 Dec; 115(6):1518-24. PubMed ID: 9834280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of placement of pancreatic duct spontaneous dislodgement stent for prevention of post-ERCP pancreatitis in patients with difficulty in selective biliary cannulation.
    Sakai Y; Tsuyuguchi T; Mikata R; Tawada K; Tada M; Togo S; Tamura R; Saito M; Kurosawa J; Ishihara T; Yokosuka O
    Hepatogastroenterology; 2011; 58(107-108):687-93. PubMed ID: 21830369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.